Alzheimer's Disease Diagnosis & Treatments
Nova Science Publishers Inc (Verlag)
978-1-61122-064-3 (ISBN)
Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's Disease (AD), which involves the parts of the brain that control thought, memory, and language. Age is the most important known risk factor for AD. The course the disease takes and the speed at which changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. This book presents research in the study of Alzheimer's Disease, including diagnosis, testing and treatment of this condition.
Preface; Alzheimers Disease -- 100 Years of Research: A Historical Perspective & Commentary; Controlled & Automatic Memory Processing in Alzheimers Disease; Age of Onset Related Differences in Clinical & Neuropsychological Features of Alzheimers Disease; Early Onset Dementia with Abundant Non-Neuritic Ass Plaques & without Significant Neuronal Loss: Report of Two Japanese Autopsy Cases; How & Where Does Ass Exert its Toxic Effects in Alzheimers Disease?; The Spatial Patterns of ss-Amyloid (Ass) Deposits & Neurofibrillary Tangles (NFT) in Late-Onset Sporadic Alzheimer's Disease; Brain Function in Altered States of Consciousness: Comparison between Alzheimer Dementia & Vegetative State; Cognitive Deficits in Mild Cognitive Impairment; Mitochondrial Pathology & Alzheimers Disease; Calmodulin Binds to & Regulates the Activity of Beta-Secretase (BACE1); Transgenic Models of Alzheimers Pathology: Success & Caveats; Relevance of COX-2 Inhibitors in Alzheimers Disease; Copper Studies in Alzheimers Disease; Theoretical Comparison of Copper Chelators as Anti-Alzheimer & Anti-Prion Agents; Toward a More Rational Approach to the Treatment of Patients with Dementia with Psychosis & Behavioral Disturbance; Amyloid Clearing Immunotherapy for Alzheimers Disease & the Risk of Cerebral Amyloid Angiopathy; Use of Antidepressants in Older People with Mental Illness; A Systematic Study of Tolerability & Use in Different Diagnostic Groups; Cystatin C Role in Alzheimer Disease: from Neurodegeneration to Neuroregeneration; A Theoretical Evaluation on Acetylcholinesterase-Inhibitory Potential of Quercetin; Therapy with Drug Product AZD-103 May Ease Alzheimer's Disease; NSAIDs in Animal Models of Alzheimer's Disease; Index.
Zusatzinfo | Illustrations |
---|---|
Verlagsort | New York |
Sprache | englisch |
Maße | 260 x 180 mm |
Gewicht | 758 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Geriatrie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie | |
ISBN-10 | 1-61122-064-5 / 1611220645 |
ISBN-13 | 978-1-61122-064-3 / 9781611220643 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich